Skip to main content
. 2019 Jul 23;10(45):4664–4678. doi: 10.18632/oncotarget.27083

Figure 8. Breast cancer-specific survival by ER status and subtypes by miR-190b methylation status.

Figure 8

Cutoff of high and low methylation was set at 20%. (A) ER+ breast cancer patients (HR = 1.35, 95% CI 0.95-1.93, P = 0.092). (B) LumA breast cancer patients (HR = 0.29, 95% CI 0.09-0.91, P = 0.034). (C) LumB breast cancer patients (HR = 1.71, 95% CI 0.76-3.86, P = 0.194). All analysis are corrected for age at diagnosis, year of diagnosis and BRCA2 mutation status.